Syra Health Q2 net loss narrows 95% to $64K; gross margin surges to 38.7%

Syra Health Corp

2025-Q2 EPS reported -$0.05 revenue$3,803,973

Net loss of $64K ($0.01 EPS) vs $1.4M loss ($0.21 EPS) in Q2 2024; adjusted EBITDA improved to ($54K) from ($1.4M).
Gross margin rose 2,090 bps to 38.7%; operating expenses declined 53% YoY to $816K.
Population Health revenue up 197% to $1.6M, driven by $5.8M FSSA contract for HCBS training.
Cash $2.3M, no long-term debt; negotiating $5.8M CMHW mental health contract with Indiana FSSA.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.